Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Ltd) |
| BNF code | 0601012W0BBAAAA |
| Virtual Medicinal Product | Insulin aspart biphasic 30/70 100units/ml suspension for injection 3ml cartridges |
| Name | NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges |
| Abbreviated name | NovoMix 30 Penfill 100units/ml inj 3ml cartridges |
| Date of name applicability | 25 Jun 2004 |
| Previous name | NovoMix 30 Penfill 100units/ml injection 3ml cartridges |
| Supplier | Novo Nordisk Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| NovoMix 30 Penfill 100units/ml suspension for injection 3ml cartridges (Novo Nordisk Ltd) 5 cartridge | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.